Mazdak A. Khalighi
No Rating Available
(Learn About Our Rating System)

Mazdak A. Khalighi, MD

Languages spoken: English

  • Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and auto-reactive diseases as well as immunofluorescence and electron microscopy. He joins the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

    Specialties

  • Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and auto-reactive diseases as well as immunofluorescence and electron microscopy. He joins the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

    Board Certification and Academic Information

    Academic Departments Dermatology -Assistant Professor (Clinical)

    Education history

    Fellowship Surgical Pathology - University of Utah School of Medicine Fellow
    Fellowship Renal Pathology - University of Chicago Fellow
    Chief Resident Anatomic Pathology - University of California, Los Angeles Chief Resident
    Residency Anatomic Pathology - University of California, Los Angeles Resident
    Internship Pediatrics - Stanford University Hospitals Intern
    Professional Medical Medicine - Jefferson Medical College M.D.
    Undergraduate Cellular and Molecular Biology - University of Michigan B.S.

    Selected Publications

    Journal Article

    1. Stone CJ, Nicholson L, Florell SR, Khalighi MA, Lewis BKH (2023). A case of secondary syphilis presenting like pemphigus with positive direct immunofluorescence. JAAD Case Rep, 42, 38-41. (Read full article)
    2. Daines B, Madigan LM, Vitale PA, Khalighi M, Innes M (2022). A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination. Dermatol Online J, 28(4). (Read full article)
    3. Leiferman KM, Snook JP, Khalighi MA, Kuechle MK, Zone JJ (2021). Diagnostics for Dermatologic Diseases with Autoantibodies. J Appl Lab Med, 7(1), 165-196. (Read full article)
    4. Mansour SG, Hall IE, Reese PP, Jia Y, Thiessen-Philbrook H, Moeckel G, Weng FL, Revelo MP, Khalighi MA, Trivedi A, Doshi MD, Schrppel B, Parikh CR (2018). Reliability of deceased-donor procurement kidney biopsy images uploaded in United Network for Organ Sharing. Clin Transplant, 32(12), e13441. (Read full article)
    5. Khalighi MA, Gallan AJ, Chang A, Meehan SM (2018). Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases. Am J Kidney Dis, 72(4), 612-616. (Read full article)
    6. Khalighi MA, Al-Rabadi L, Chalasani M, Smith M, Kakani S, Revelo MP, Meehan SM (2018). Staphylococcal Infection-Related Glomerulonephritis With Cryoglobulinemic Features. Kidney Int Rep, 3(5), 1128-1134. (Read full article)
    7. Lloyd IE, Ahmed F, Revelo MP, Khalighi MA (2018). De novo immune complex deposition in kidney allografts: a series of 32 patients. Hum Pathol, 71, 109-116.
    8. Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, Khalighi MA (2016). C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clin Kidney J, 9(6), 794-799. (Read full article)
    9. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Meehan SM, Chang A (2016). Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy. Clin Kidney J, 9(3), 397-402. (Read full article)
    10. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Chang A, Meehan SM (2015). Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Pediatr Nephrol, 30(6), 953-9. (Read full article)
    11. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng, J, Rastogi A, Chen W, Grossman JM (2012). American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res, 64(6), 797-808.
    12. Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed EF (2011). Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection. Transplantation, 92(4), 388-95. (Read full article)

    Review

    1. Khalighi MA, Chang A (2021). Infection-Related Glomerulonephritis. [Review]. Glomerular Dis, 1(2), 82-91. (Read full article)

    Case Report

    1. Jimenez A, Blain K, Khalighi M, Clarke JT, Snook J, Cipriano SD (2021). Neonatal pemphigoid gestationis: An atypical presentation of a rare disease. Pediatr Dermatol, 38(6), 1575-1576. (Read full article)
    2. Kukull BJ, Khalighi MA, Gundle KR, Hansford BG, Corless CL, Davis JL (2019). Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient. Pediatr Dev Pathol, 23(3), 240-246. (Read full article)